During the past decade, Klinikum Osnabrück, Klinik für Neurologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Osnabrück, Klinik für Neurologie" are "Intracranial Stenosis" (1 trials) and "Relapsing Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Klinikum Osnabrück, Klinik für Neurologie" in a lesser frequency.

Most popular intervention types in "Klinikum Osnabrück, Klinik für Neurologie" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Credo® Stent, NeuroSpeed® PTA balloon catheter" (1 trials), "Placebo" (1 trials) and "Pleneva TM BGC20-0134" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Osnabrück, Klinik für Neurologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Osnabrück, Klinik für Neurologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klinikum Osnabrück, Klinik für Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Osnabrück, Klinik für Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".